Seebri Breezhaler Description

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Each inhalation powder capsule contains glycopyrronium bromide 63 mcg equivalent to glycopyrronium 50 mcg .
It also contains the following excipients: Capsule fill: Lactose monohydrate and magnesium stearate. Capsule shell components: Hypromellose, purified water, carrageenan, potassium chloride and FDC yellow 6 (110 sunset yellow FCF).
The delivered dose (the dose that leaves the mouthpiece of Seebri Breezhaler inhaler) is equivalent to glycopyrronium 44 mcg.

Seebri Breezhaler Description

glycopyrronium bromide

Manufacturer:

Novartis Indonesia

Marketer:

Wellesta